查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600546

血液培养测试市场：按产品、技术、应用和最终用户分类 - 全球预测 2025-2030

Blood Culture Test Market by Product (Consumable, Instrument, Software and Services), Technology (Culture-Based Technology, Molecular Technology, Proteomics Technology), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

血液培养检测市场2023年估值为42.3亿美元，预计到2024年将达到44.9亿美元，复合年增长率为6.18%，预计到2030年将达到64.4亿美元。

血液培养检查是一种重要的诊断工具，用于检测血液中是否存在细菌和真菌，这可能导致败血症等严重感染疾病。这些测试的需求源于它们在指导有效治疗计划方面的作用，因为及时识别病原体可以显着改善患者的治疗结果。这些测试广泛应用于各种医疗机构，包括医院、诊所和实验室。最终用途范围涵盖重症加护病房(ICU)、急诊室和门诊病人设施等各个领域，凸显了其在医疗保健系统中的广泛性。

主要市场统计
基准年[2023] 42.3亿美元
预测年份 [2024] 44.9亿美元
预测年份 [2030] 64.4亿美元
复合年增长率（%） 6.18%

根据市场洞察，败血症和血流感染疾病发病率的增加以及对快速诊断技术的需求不断增长是市场成长的关键驱动力。自动化和灵敏的血液培养系统的开发等技术进步也刺激了市场扩张。此外，人们对早期疾病诊断和抗菌药物管理计划重要性的认识不断提高也有助于扩大市场机会。

然而，先进测试技术的高成本和严格的监管要求等挑战可能会阻碍市场成长。此外，需要技术人员来执行这些测试，这可能会造成额外的障碍，特别是在医疗保健资源有限的地区。

创新可以集中于透过分子诊断和就地检验解决方案来提高血液培养检测的速度和准确性。开发具有成本效益的替代方案并整合人工智慧主导的分析以获得预测性见解也可以提供重要的业务成长机会。市场动态显示逐渐转向自动化和个人化医疗，重点是缩短获得结果的时间并增加使用者的可及性。寻求新商机的公司可能会发现投资伙伴关係以促进技术进步或透过量身定制的解决方案进入新兴市场非常有用。总体而言，市场将经历相当大的演变，大力推动测试方法的创新，以解决现有的限制并满足不断增长的临床需求。

市场动态：快速发展的血液培养测试市场的关键市场洞察

供需的动态交互作用正在改变血液培养检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于血液感染疾病和感染疾病率不断增加，需要照护现场和快速诊断检测
    • 增加公共和私人医疗保健支出以改善诊断
    • 政府支持和核准、临床和实验室报销政策
  • 市场限制因素
    • 与受污染的血液培养相关的潜在风险
  • 市场机会
    • 活性化在诊断测试和方法方面的研发 (R&D) 活动
    • 更多采用自动化血液培养测试
  • 市场挑战
    • 政府对血液培养开发和生产有严格的规范

波特五力：驾驭血液培养检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对血液培养检测市场的影响

外部宏观环境因素对血液培养检测市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血液培养检测市场的竞争状况

对血液培养测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血液培养检测市场供应商绩效评估

FPNV定位矩阵是评估血液培养检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分了供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着血流感染疾病和感染疾病的增加，需要就地检验和快速诊断测试
      • 增加致力于改善诊断的公共和私人医疗保健支出
      • 政府支持和核准、临床和实验室报销政策
    • 抑制因素
      • 与受污染的血液培养相关的潜在风险
    • 机会
      • 推动诊断测试和方法的新研发 (R&D) 活动
      • 更多采用自动化血液培养测试
    • 任务
      • 严格的政府血液培养开发和生产标准
  • 市场区隔分析
    • 产品：软体不断进步，增强了血液培养资料分析和报告的自动化。
    • 技术：分子技术对病原体的快速和特异性检测的重要性日益增加
    • 应用：血流感染疾病盛行率的增加正在推动血液培养检测的使用
    • 最终用户：学术研究机构越来越多地使用血液培养检测来提高病原体检测的特异性和灵敏度。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章血液培养检测市场：副产品

  • 消耗品
  • 装置
  • 软体和服务

第七章血液培养检测市场：依技术分类

  • 基于文化的技术
  • 分子技术
  • 蛋白质体学技术

第八章血液培养检测市场：依应用分类

  • 菌血症
  • 真菌血症
  • 结核分枝桿菌检测

第九章血液培养检测市场：依最终用户分类

  • 学术研究室
  • 医院实验室
  • 参考实验室

第十章美洲血液培养检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区血培养检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲血液培养检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Universal DX 宣布与 Quest Diagnostics 建立战略合作伙伴关係，为美国患者和医疗保健提供者提供先进的结直肠癌筛检血液检测
    • BD 和 Magnolia Medical Technologies 宣布建立商业合作伙伴关係，以减少血液培养污染并提高测试准确性
    • Accelerate Diagnostics 发布用于血液培养测试的 Arc 系统

公司名单

  • OpGen, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Bruker Corporation
  • Devyser AB
  • Juno Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.
  • Biomerieux SA
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • ZeptoMetrix Corporation
  • Terumo Corporation
  • Novartis AG
  • Neogen Corporation
  • Eli Lilly and Company
  • BINDER GmbH
  • HiMedia Laboratories Pvt. Ltd.
  • Scenker Biological Technology Co., Ltd.
  • T2 Biosystems, Inc.
  • Anaerobe Systems, Inc.
Product Code: MRR-035DA3C63737

The Blood Culture Test Market was valued at USD 4.23 billion in 2023, expected to reach USD 4.49 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 6.44 billion by 2030.

Blood culture tests are a critical diagnostic tool used to detect the presence of bacteria or fungi in the blood, which can lead to severe infections such as sepsis. The necessity of these tests stems from their role in guiding effective treatment plans, as timely identification of pathogens can drastically improve patient outcomes. These tests have widespread applications across various healthcare settings, including hospitals, clinics, and laboratories. The end-use scope extends to different departments such as intensive care units (ICUs), emergency rooms, and outpatient facilities, emphasizing their breadth in healthcare systems.

KEY MARKET STATISTICS
Base Year [2023] USD 4.23 billion
Estimated Year [2024] USD 4.49 billion
Forecast Year [2030] USD 6.44 billion
CAGR (%) 6.18%

Market insights reveal that the growing incidence of sepsis and bloodstream infections, coupled with the rising demand for rapid diagnostic techniques, are significant driving factors for market growth. Advances in technology, such as the development of automated and more sensitive blood culture systems, are also stimulating market expansion. Additionally, increasing awareness about early disease diagnosis and the importance of antimicrobial stewardship programs contribute to market opportunities.

However, challenges such as high costs of advanced testing technologies and stringent regulatory requirements may impede market growth. Moreover, the need for skilled personnel to conduct these tests can pose additional barriers, particularly in regions with limited healthcare resources.

Innovation could focus on enhancing the speed and accuracy of blood culture tests through molecular diagnostics and point-of-care testing solutions. Developing cost-effective alternatives and integrating AI-driven analytics for predictive insights could also offer substantial business growth opportunities. Market dynamics suggest a gradual shift towards automation and personalized medicine, with an emphasis on reducing time-to-result and improving user accessibility. For businesses looking to explore new opportunities, investing in partnerships for technological advancement or entering emerging markets with tailored solutions could be beneficial. Overall, the market is poised for considerable evolution, with a strong push towards innovation in testing methods to address existing limitations and meet growing clinical demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Culture Test Market

The Blood Culture Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
    • Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
    • Government Support and Approval Along with Clinical and Lab Reimbursement Policies
  • Market Restraints
    • Potential Risk Associated with Contaminated Blood Culture
  • Market Opportunities
    • Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
    • Rising Adoption of Automated Blood Culture Tests
  • Market Challenges
    • Strict Government Norms in the Development and Production of Blood Cultures

Porter's Five Forces: A Strategic Tool for Navigating the Blood Culture Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Culture Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Culture Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Culture Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Culture Test Market

A detailed market share analysis in the Blood Culture Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Culture Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Culture Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Blood Culture Test Market, highlighting leading vendors and their innovative profiles. These include OpGen, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Bruker Corporation, Devyser AB, Juno Diagnostics, Inc., Thermo Fisher Scientific, Inc., Biomerieux SA, Biobase Biodusty(Shandong), Co., Ltd., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, F. Hoffmann-La Roche Ltd., ZeptoMetrix Corporation, Terumo Corporation, Novartis AG, Neogen Corporation, Eli Lilly and Company, BINDER GmbH, HiMedia Laboratories Pvt. Ltd., Scenker Biological Technology Co., Ltd., T2 Biosystems, Inc., and Anaerobe Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumable, Instrument, and Software and Services.
  • Based on Technology, market is studied across Culture-Based Technology, Molecular Technology, and Proteomics Technology.
  • Based on Application, market is studied across Bacteremia, Fungemia, and Mycobacterial Detection.
  • Based on End User, market is studied across Academic Research Laboratories, Hospital Laboratories, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
      • 5.1.1.2. Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
      • 5.1.1.3. Government Support and Approval Along with Clinical and Lab Reimbursement Policies
    • 5.1.2. Restraints
      • 5.1.2.1. Potential Risk Associated with Contaminated Blood Culture
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
      • 5.1.3.2. Rising Adoption of Automated Blood Culture Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Government Norms in the Development and Production of Blood Cultures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing advancement in the softwares to enhance automation in blood culture data analysis and reporting.
    • 5.2.2. Technology: Growing significance of molecular technology due to its rapid and specific detection of pathogens
    • 5.2.3. Application: Increasing prevalence of bloodstream infections driving the utilization of blood culture test
    • 5.2.4. End User: Rising utilization of blood culture test by academic research laboratories for to enhance the specificity and sensitivity of pathogen detection
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Blood Culture Test Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instrument
  • 6.4. Software and Services

7. Blood Culture Test Market, by Technology

  • 7.1. Introduction
  • 7.2. Culture-Based Technology
  • 7.3. Molecular Technology
  • 7.4. Proteomics Technology

8. Blood Culture Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bacteremia
  • 8.3. Fungemia
  • 8.4. Mycobacterial Detection

9. Blood Culture Test Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Laboratories
  • 9.3. Hospital Laboratories
  • 9.4. Reference Laboratories

10. Americas Blood Culture Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Culture Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Culture Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
    • 13.3.2. BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy
    • 13.3.3. Accelerate Diagnostics Launches Arc System for Use in Blood Culture Test

Companies Mentioned

  • 1. OpGen, Inc.
  • 2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 3. Bruker Corporation
  • 4. Devyser AB
  • 5. Juno Diagnostics, Inc.
  • 6. Thermo Fisher Scientific, Inc.
  • 7. Biomerieux SA
  • 8. Biobase Biodusty(Shandong), Co., Ltd.
  • 9. Autobio Diagnostics Co., Ltd.
  • 10. Becton, Dickinson and Company
  • 11. Abbott Laboratories
  • 12. Siemens Healthineers AG
  • 13. Danaher Corporation
  • 14. F. Hoffmann-La Roche Ltd.
  • 15. ZeptoMetrix Corporation
  • 16. Terumo Corporation
  • 17. Novartis AG
  • 18. Neogen Corporation
  • 19. Eli Lilly and Company
  • 20. BINDER GmbH
  • 21. HiMedia Laboratories Pvt. Ltd.
  • 22. Scenker Biological Technology Co., Ltd.
  • 23. T2 Biosystems, Inc.
  • 24. Anaerobe Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD CULTURE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD CULTURE TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CULTURE-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PROTEOMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2023